CLINICAL_TRIALS
trial_result
· 2023-10-16
Clinical Trial Update: CyclASol for the Treatment of Signs and Symptoms of Dry Eye Disease in Subjects Who Completed CYS-004 [Phase 3]
Summary
Phase 3 trial update for CyclASol in dry eye disease has completed enrollment with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novaliq GmbH | Conditions: Dry Eye Disease (DED) | Phase 3 | Status: COMPLETED | Results posted: 2023-10-16